Literature DB >> 25150263

[Pharmacokinetics and pharmacodynamics of antibiotic therapy].

S Beck1, S G Wicha, C Kloft, M G Kees.   

Abstract

Antibiotic agents are crucial pillars in intensive care medicine and must be used rationally and sensibly. In the case of critically ill patients optimal dosing with respect to pharmacokinetic and pharmacodynamic principles (PK/PD) can be vital. Preclinical results demonstrated important differences between antibiotic classes and gave rise to differing clinical dosing strategies, e.g. high dose once daily regimens for aminoglycosides or extended/continuous infusion of betalactams. Critically ill patients with altered pharmacokinetic parameters and infections by pathogens with low susceptibility are most likely to benefit from PK/PD-guided therapy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25150263     DOI: 10.1007/s00101-014-2369-9

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  28 in total

Review 1.  Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an update.

Authors:  Johan W Mouton; Michael N Dudley; Otto Cars; Hartmut Derendorf; George L Drusano
Journal:  J Antimicrob Chemother       Date:  2005-03-16       Impact factor: 5.790

2.  Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship.

Authors:  Timothy H Dellit; Robert C Owens; John E McGowan; Dale N Gerding; Robert A Weinstein; John P Burke; W Charles Huskins; David L Paterson; Neil O Fishman; Christopher F Carpenter; P J Brennan; Marianne Billeter; Thomas M Hooton
Journal:  Clin Infect Dis       Date:  2006-12-13       Impact factor: 9.079

3.  Clinical cure of ventilator-associated pneumonia treated with piperacillin/tazobactam administered by continuous or intermittent infusion.

Authors:  Leonardo Lorente; Alejandro Jiménez; María M Martín; José Luis Iribarren; Juan José Jiménez; María L Mora
Journal:  Int J Antimicrob Agents       Date:  2009-01-15       Impact factor: 5.283

Review 4.  In vitro pharmacodynamic models to determine the effect of antibacterial drugs.

Authors:  Julia Gloede; Christian Scheerans; Hartmut Derendorf; Charlotte Kloft
Journal:  J Antimicrob Chemother       Date:  2009-12-21       Impact factor: 5.790

5.  Comparison of clinical cure rates in adults with ventilator-associated pneumonia treated with intravenous ceftazidime administered by continuous or intermittent infusion: a retrospective, nonrandomized, open-label, historical chart review.

Authors:  Leonardo Lorente; Alejandro Jiménez; Salome Palmero; Juan José Jiménez; José Luís Iribarren; Melitón Santana; María M Martín; Maria L Mora
Journal:  Clin Ther       Date:  2007-11       Impact factor: 3.393

Review 6.  Experimental endocarditis: a review of its relevance to human endocarditis.

Authors:  C Carbon
Journal:  J Antimicrob Chemother       Date:  1993-05       Impact factor: 5.790

Review 7.  Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins.

Authors:  W A Craig
Journal:  Diagn Microbiol Infect Dis       Date:  1995 May-Jun       Impact factor: 2.803

Review 8.  Aminoglycosides in septic shock: an overview, with specific consideration given to their nephrotoxic risk.

Authors:  Alexandre Boyer; Didier Gruson; Stéphane Bouchet; Benjamin Clouzeau; Bui Hoang-Nam; Frédéric Vargas; Hilbert Gilles; Mathieu Molimard; Anne-Marie Rogues; Nicholas Moore
Journal:  Drug Saf       Date:  2013-04       Impact factor: 5.606

9.  Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients.

Authors:  A Forrest; D E Nix; C H Ballow; T F Goss; M C Birmingham; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

10.  Single or multiple daily doses of aminoglycosides: a meta-analysis.

Authors:  M Barza; J P Ioannidis; J C Cappelleri; J Lau
Journal:  BMJ       Date:  1996-02-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.